These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 15288835

  • 1. Expression of tumor necrosis factor-alpha and its soluble receptors in betel-quid-chewing patients at different stages of treatment for oral squamous cell carcinoma.
    Su TR, Chang KL, Lee CH, Chen CH, Yang YH, Shieh TY.
    Oral Oncol; 2004 Sep; 40(8):804-10. PubMed ID: 15288835
    [Abstract] [Full Text] [Related]

  • 2. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
    Jablońska E, Kiluk M, Piotrowski L, Grabowska Z, Markiewicz W, Jablonski J.
    Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
    [Abstract] [Full Text] [Related]

  • 3. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
    Tesar V, Jirsa M, Masek Z, Bartůnková J, Stejskalová A, Dostál C, Zabka J, Chábová V, Rysavá R.
    Cas Lek Cesk; 1998 May 04; 137(9):271-5. PubMed ID: 9650355
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
    Gregorc V, Spreafico A, Floriani I, Colombo B, Ludovini V, Pistola L, Bellezza G, Viganò MG, Villa E, Corti A.
    Cancer; 2007 Aug 15; 110(4):845-53. PubMed ID: 17599769
    [Abstract] [Full Text] [Related]

  • 5. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J, Stabuc B, Rudolf Z, Galvani V, Curin-Serbec V.
    Melanoma Res; 2000 Jun 15; 10(3):253-8. PubMed ID: 10890379
    [Abstract] [Full Text] [Related]

  • 6. Enhanced expression and shedding of tumor necrosis factor (TNF) receptors from mononuclear leukocytes in human heart failure.
    Nozaki N, Yamaguchi S, Yamaoka M, Okuyama M, Nakamura H, Tomoike H.
    J Mol Cell Cardiol; 1998 Oct 15; 30(10):2003-12. PubMed ID: 9799654
    [Abstract] [Full Text] [Related]

  • 7. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P, Kvasnicka J, Umlaufová A, Homolková H, Jirsa M, Tesar V.
    Med Sci Monit; 2000 Oct 15; 6(4):661-7. PubMed ID: 11208388
    [Abstract] [Full Text] [Related]

  • 8. Specific induction of the high-molecular-weight microtubule-associated protein 2 (hmw-MAP2) by betel quid extract in cultured oral keratinocytes: clinical implications in betel quid-associated oral squamous cell carcinoma (OSCC).
    Chen JY, Chang YL, Yu YC, Chao CC, Kao HW, Wu CT, Lin WC, Ko JY, Jou YS.
    Carcinogenesis; 2004 Feb 15; 25(2):269-76. PubMed ID: 14604896
    [Abstract] [Full Text] [Related]

  • 9. The upregulation of metallothionein-1 expression in areca quid chewing-associated oral squamous cell carcinomas.
    Lee SS, Yang SF, Ho YC, Tsai CH, Chang YC.
    Oral Oncol; 2008 Feb 15; 44(2):180-6. PubMed ID: 17418620
    [Abstract] [Full Text] [Related]

  • 10. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
    Núñez-González JR, Sanabria-Vera CJ, Romero-Adrián T.
    Invest Clin; 2001 Sep 15; 42(3):171-81. PubMed ID: 11552506
    [Abstract] [Full Text] [Related]

  • 11. [Soluble TNF and IL-2 receptors in patients with breast carcinoma].
    Tesarová P, Kvasnicka J, Umlaufová A, Homolková J, Jirsa M, Tesar V.
    Cas Lek Cesk; 1998 May 25; 137(11):341-5. PubMed ID: 9727208
    [Abstract] [Full Text] [Related]

  • 12. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease].
    Mizia-Stec K, Mandecki T, Zahorska-Markiewicz B, Janowska J, Szulc A, Jastrzebska-Maj E, Szymański L.
    Pol Merkur Lekarski; 2001 Jul 25; 11(61):19-25. PubMed ID: 11579824
    [Abstract] [Full Text] [Related]

  • 13. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure.
    van Riemsdijk-van Overbeeke IC, Baan CC, Hesse CJ, Loonen EH, Niesters HG, Zietse R, Weimar W.
    Clin Nephrol; 2000 Feb 25; 53(2):115-23. PubMed ID: 10711413
    [Abstract] [Full Text] [Related]

  • 14. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
    Jabłońska E, Pietruska Z.
    Arch Immunol Ther Exp (Warsz); 1997 Feb 25; 45(5-6):449-53. PubMed ID: 9437501
    [Abstract] [Full Text] [Related]

  • 15. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
    Chen CH, Lin YS, Lin CC, Yang YH, Ho YP, Tsai CC.
    J Oral Pathol Med; 2004 Nov 25; 33(10):589-94. PubMed ID: 15482324
    [Abstract] [Full Text] [Related]

  • 16. [Effects of high-volume hemofiltration on serum levels of tumor necrosis factor and its receptors in patients with multiple organ dysfunction syndromes].
    Zhang J, Tao LJ, Ning JP, Xu H, Ai YH, Zhao SP.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Feb 25; 16(2):81-4. PubMed ID: 14764220
    [Abstract] [Full Text] [Related]

  • 17. The role of soluble TNF receptors for TNF-alpha in uveitis.
    Sugita S, Takase H, Taguchi C, Mochizuki M.
    Invest Ophthalmol Vis Sci; 2007 Jul 25; 48(7):3246-52. PubMed ID: 17591895
    [Abstract] [Full Text] [Related]

  • 18. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy.
    Himmerich H, Beitinger PA, Fulda S, Wehrle R, Linseisen J, Wolfram G, Himmerich S, Gedrich K, Wetter TC, Pollmächer T.
    Arch Intern Med; 2006 Sep 18; 166(16):1739-43. PubMed ID: 16983052
    [Abstract] [Full Text] [Related]

  • 19. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
    Glossop JR, Dawes PT, Nixon NB, Mattey DL.
    Arthritis Res Ther; 2005 Sep 18; 7(6):R1227-34. PubMed ID: 16277675
    [Abstract] [Full Text] [Related]

  • 20. [Serum concentration and urinary excretion of soluble receptors for tumor necrosis factor in patients with primary glomerulonephritis].
    Kacprzyk F.
    Pol Merkur Lekarski; 2003 Oct 18; 15(88):383-6; discussion 386-7. PubMed ID: 14974372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.